Molbio Diagnostics IPO Subscription Status
Molbio Diagnostics IPO was subscribed 70.26 times when bidding closed on 12 Aug 2026: QIB 186.39x, NII 49.8x, Retail 12.96x.
The Molbio Diagnostics IPO has been subscribed 70.26x times overall. Retail investors have shown interest with bids for 12.96x the shares available. The Non-Institutional Investor (NII) category has been subscribed 49.8x. Within NII, Big HNI (B-HNI) subscribed 50.82x and Small HNI (S-HNI) subscribed 47.76x. Qualified Institutional Buyers (QIBs) have subscribed 186.39x. Data last updated on 08 Sep, 01:37 PM.
The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 10 Aug, 2026 and closes on 12 Aug, 2026. The shares are expected to list on stock exchanges on 17 Aug, 2026.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Live bidding
Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.
| Category | Bid details | Times |
|---|---|---|
| QIB | 43,33,82,148 of 23,25,145 139 applications 34,973.94 Cr | 186.39x |
| NII | 8,68,40,604 of 17,43,860 1,52,244 applications 7,008.04 Cr | 49.8x |
bHNI — bid amount above ₹10 Lakh |
5,90,76,594 46,229 applications 4,767.48 Cr | 50.82 |
sHNI — bid amount ₹2–10 Lakh |
2,77,64,010 1,06,015 applications 2,240.56 Cr | 47.76 |
| Retail | 5,27,19,318 of 40,69,005 24,54,316 applications 4,254.45 Cr | 12.96x |
| Employee | 2,72,466 of 20,519 469 applications 21.99 Cr | 13.28x |
| TOTAL | 57,32,14,536 26,07,168 applications 46,258.41 Cr | 70.26x |
Molbio Diagnostics IPO Basis of Allotment
Final Final figures published by the registrar, after technical rejections. Allotment price ₹807, employees ₹731.
| Category | AppsApplications | GotAllottees | Odds |
|---|---|---|---|
| QIB 75.13x subscribed | 172 | 0 | -- |
|
Ex. Anchor
Ex. Anchor
|
139 | 0 | -- |
|
Anchor
Anchor Investors
|
33 | 22 | 2 out of 32 out of 3 |
| NII (HNI) 49.62x subscribed | 1,52,244 | 6,919 | 1 out of 221 out of 22 |
|
bNII >₹10L
bNII — above ₹10 Lakh
|
46,229 | 4,613 | 1 out of 101 out of 10 |
|
sNII <₹10L
sNII — below ₹10 Lakh
|
1,06,015 | 2,306 | 1 out of 461 out of 46 |
| Retail 12.65x subscribed | 24,54,316 | 2,26,055 | 1 out of 101 out of 10 |
| Employees 1.95x subscribed | 469 | 469 | AllAll allotted |
| TOTAL 49.35x subscribed | 26,07,201 | 2,33,443 | 1 out of 111 out of 11 |
Molbio Diagnostics IPO allotment probability
Your odds of an allotment in each category at the current subscription.
Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.
Subscription insights
What the current book is saying, read off the category numbers above.
Retail Allotment
Subscription is above 1x. While a lottery is guaranteed, your probability of allotment is approximately 7.7% for a single lot.
Institutional Backing
Massive institutional interest with QIBs subscribing 186.39x. This often signals long-term confidence from professional funds.
Day-wise subscription history
End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.
| Date | Total | ||
|---|---|---|---|
|
12 Aug 2026
Day 3 |
70.26x | ▼ | |
|
QIB186.39x
BHNI50.82x
SHNI47.76x
Retail12.96x
Employee13.28x
|
|||
|
11 Aug 2026
Day 2 |
3.11x | ▼ | |
|
QIB1.39x
BHNI4.31x
SHNI7.01x
Retail3.18x
Employee4.78x
|
|||
|
10 Aug 2026
Day 1 |
0.83x | ▼ | |
|
QIB1x
BHNI0.7x
SHNI0.8x
Retail0.77x
Employee2.12x
|
|||
Molbio Diagnostics IPO dates
From the bidding window to listing. Today is 6 November.
- Open 10 Aug 2026
- Close 12 Aug 2026
- Allotment 13 Aug 2026
- Refund/credit 14 Aug 2026
- Listing 17 Aug 2026
Anchor investor allocation
Shares allotted to anchor investors the working day before the issue opened.
What does this subscription data mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.
Frequently asked
What is the current subscription status of Molbio Diagnostics IPO?
As of IPO close date (12 Aug, 2026), the Molbio Diagnostics IPO is subscribed 70.26x times. Retail category is 12.96x, and NII is 49.8x subscribed.
When is the allotment date for Molbio Diagnostics IPO?
The allotment for Molbio Diagnostics IPO is expected to be finalized on 13 August, 2026.
What is the GMP of Molbio Diagnostics?
The Grey Market Premium (GMP) for Molbio Diagnostics is currently ₹120, indicating a potential listing gain of 14.87%.
When will Molbio Diagnostics IPO list on the stock market?
Molbio Diagnostics is scheduled to list on BSE and NSE on 17 August, 2026.
What are the chances of getting allotment in Molbio Diagnostics IPO?
The retail category is oversubscribed at 12.96x, meaning allotment is by lottery. Statistically, approximately 1 in 13 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
What does QIB subscription of 186.39x mean for Molbio Diagnostics IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 186.39x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Molbio Diagnostics IPO allotment status?
After the allotment date (13 Aug, 2026), you can check your Molbio Diagnostics IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Molbio Diagnostics IPO further
Track every stage of this IPO, from subscription to listing.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
Subscription moves by the hour. Get it on your phone.
Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.
Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.
